BloomX raises $13M Series A to sell robotic pollination as a scheduled service
The Elah Fund led a $13 million Series A for BloomX, an Israeli agtech company that has raised $20 million since its 2019 founding. BloomX sells its pollination systems as a service, and the company says client growers have averaged about 20% higher yields.
Israeli agtech company BloomX has raised a $13 million Series A led by the Elah Fund, bringing its total since its 2019 founding to $20 million, Calcalist reported on Oct 15. OurCrowd, BioBee and the Israel Innovation Authority also took part.
BloomX sells pollination as a scheduled farm input, the way growers already plan irrigation, and the robots are only the delivery method. Growers get the machines without significant upfront investment under a model the company calls Pollination-as-a-Service, a form of robots-as-a-service. The round pays for expansion in Peru, Mexico, South Africa and Israel and for a U.S. entry aimed at almond and blueberry growers, where the company-reported average yield gain of about 20% will have to hold in orchards BloomX has not yet worked.
Robee, built for blueberries, shakes plants with controlled vibrations that mimic bumblebee buzz pollination. The Yahav 2400, launched commercially for avocados this year, uses a high-voltage electrostatic field to pull pollen from male flowers onto a fabric that mimics a bee's body, holds it overnight, then rubs it onto female flowers.
BloomX says growers including Agrícola Cerro Prieto and Fruitist in Peru, Allesbeste in South Africa and Israel's Granot Group averaged that 20% gain, with returns of up to 10.5 times and one operator covering up to 3.5 hectares a day. Those figures are the company's own. CEO Thai Sade also says the technology "does not replace bees but works alongside them," which means U.S. growers may keep paying for hives on top of the service.
Sources Sources verified
Related briefings
More in Funding & CompaniesMultiply Labs raises $75M Series B for robotic biomanufacturing
NantWorks led a $75M Series B for Multiply Labs. AstraZeneca, which has been evaluating its cell-therapy robots since January, is now an investor.
Stockholm's 120ft raises EUR 576,000 to run humanoid microfactories in shipping containers
Swedish startup 120ft Factory AB launched Oct 15 with EUR 576,000 from 22 angel investors to build microfactories in three 40-foot shipping containers, run by humanoid robots shared across customers. Brands pay per finished product rather than buying robots, and production runs start at 100 units.
Hurotics raises 25 billion won to take a soft walking exosuit abroad
The Korean wearable-robot maker closed a Series A led by Atinum, with Daewoong, NAVER and Lotte joining. Cumulative funding is above 33.5 billion won.
Newsletter
Robrief Weekly
One email a week with the robotics news that matters. Free, unsubscribe anytime.